Division of Clinical Epidemiology and Aging Research, German Cancer Research Center, Heidelberg, Germany.
Clin Gastroenterol Hepatol. 2010 Oct;8(10):870-6. doi: 10.1016/j.cgh.2010.07.004. Epub 2010 Jul 27.
BACKGROUND & AIMS: Screening recommendations for colorectal cancer (CRC) commonly take family history but no other risk factors into account. We compared and assessed risk factors of colorectal polyps in a large population undergoing screening colonoscopy.
We conducted a population-based cross-sectional study that included 3349 subjects, 55 years or older (mean ages of men and women, 63.6 and 63.4 years, respectively), who underwent colonoscopy for the first time within the nationwide colonoscopy screening program in Germany. We calculated prevalences of colorectal polyps and estimated multivariate prevalence ratios (PRs) and population attributable fractions (PAFs).
Overall, 654 subjects had hyperplastic polyps (20%), 675 had non-advanced adenomas (20%), 343 had advanced adenomas (10%), and 40 had CRC (1%). Risk factor prevalences and adjusted PRs were higher for male gender and smoking than for family history of CRC. PAFs for prevalence of non-advanced and advanced neoplasia were highest for male gender (23% and 23%, respectively), followed by smoking (7% and 9%, respectively), and family history of CRC (2% and 4%, respectively).
Male gender and smoking have a larger impact on the prevalence of colorectal neoplasia than family history, suggesting an extensive evaluation of additional risk stratification in population-based screening, particularly by sex.
结直肠癌(CRC)的筛查建议通常只考虑家族史,而不考虑其他危险因素。我们比较并评估了在接受大规模筛查性结肠镜检查的人群中,结直肠息肉的危险因素。
我们进行了一项基于人群的横断面研究,纳入了 3349 名年龄在 55 岁及以上(男性和女性的平均年龄分别为 63.6 岁和 63.4 岁)的受试者,他们在德国全国范围内的结肠镜筛查计划中首次接受了结肠镜检查。我们计算了结直肠息肉的患病率,并估计了多变量患病率比(PR)和人群归因分数(PAF)。
总体而言,654 名受试者患有增生性息肉(20%),675 名受试者患有非进展性腺瘤(20%),343 名受试者患有进展性腺瘤(10%),40 名受试者患有 CRC(1%)。与家族史相比,男性性别和吸烟的风险因素患病率和调整后的 PR 更高。非进展性和进展性肿瘤的 PAF 对于男性来说最高(分别为 23%和 23%),其次是吸烟(分别为 7%和 9%),以及 CRC 家族史(分别为 2%和 4%)。
与家族史相比,男性性别和吸烟对结直肠肿瘤的患病率有更大的影响,这表明在基于人群的筛查中,需要更广泛地评估其他风险分层,特别是按性别进行评估。